Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
6,570 Prostate Cancer
clinical trials

Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Paramus, NJ
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Towson, MD
Click here to add this to my saved trials
Metastatic Castration-resistant Prostate Cancer Clinical Trial
Study on Olaparib Plus Abiraterone as First-line Therapy in Men With Metastatic Castration-resistant Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Icahn School of Medicine at Mount Sinai - The Derald H. Ruttenberg
mi
from
New York, NY
Click here to add this to my saved trials
Metastatic Prostate Cancer Clinical Trial
A Study of Niraparib in Combination With Abiraterone Acetate and Prednisone Versus Abiraterone Acetate and Prednisone for Treatment of Participants With Metastatic Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Urology of Virginia, PLCC
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Metastatic Castration Resistant Prostate Cancer Clinical Trial
To Evaluate Safety and Tolerability of VERU-111 in Men With Advanced Metastatic Castration Resistant Prostate Cancer
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Chesapeake Urology
mi
from
Towson, MD
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of Olaparib and Durvalumab in Prostate Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Memoral Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors
Status: Enrolling, Phase I
Updated: 12/31/1969
mi
from
Heidelberg,
Click here to add this to my saved trials
Prostatic Neoplasm Clinical Trial
Restore: Improving Sexual Outcomes of Gay and Bisexual Prostate Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
University of Minnesota - Twin Cities Campus
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Prostate Cancer Metastatic Clinical Trial
A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Status: Enrolling, Phase I
Updated: 12/31/1969
UCLA Institute of Urologic Oncology
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Monterey, CA
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma
Status: Enrolling, Phase
Updated: 12/31/1969
Clinical Research Facility
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase I
Updated: 5/28/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
A Study of the Safety and Pharmacokinetics of Escalating Doses of DSTP3086S in Patients With Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase I
Updated: 5/28/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Norfolk, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Norwich, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Ocala, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Peoria, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Rancho Mirage, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
West Reading, PA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Study of Hypo-fractionated Proton Radiation for Low Risk Prostate Cancer
Status: Enrolling, Phase III
Updated: 1/16/2018
Maryland Proton Treatment Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Urothelial Carcinoma Clinical Trial
Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy in Patients With High-Grade Upper Tract Urothelial Carcinoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Baptist Alliance MCI
mi
from
Miami, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Cleveland Clinic Akron General
mi
from
Akron, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
McFarland Clinic PC - Ames
mi
from
Ames, IA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Feather River Cancer Center
mi
from
Chico, CA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Maryland Radiation Oncology Center at Union Hospital
mi
from
Elkton, MD
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Northeast Georgia Medical Center-Gainesville
mi
from
Gainesville, GA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
UH Seidman Cancer Center at Southwest General Hospital
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Marshfield Medical Center-Rice Lake
mi
from
Rice Lake, WI
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Sentara Obici Hospital
mi
from
Suffolk, VA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Southwest Illinois Health Services LLP
mi
from
Swansea, IL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
NHRMC Radiation Oncology - 16th Street
mi
from
Wilmington, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Allentown, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Bettendorf, IA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Binghamton, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Burlington, VT
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Duarte, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Dunkirk, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Durham, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
East Syracuse, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Glendale, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Hendersonville, NC
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Marina Del Rey, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Massillon, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Memphis, TN
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Morristown, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
Mt. Kisco, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
New Britain, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer
Status: Enrolling, Phase III
Updated: 3/23/2017
Clinical Research Facility
mi
from
New Orleans, LA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Radiation Centers of New York
mi
from
Hartsdale, NY
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Arizona Oncology Services Foundation
mi
from
Multiple Locations, AZ
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
21st Century Oncology
mi
from
Naples, FL
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Advanced Radiation Centers of New York
mi
from
Plainview, NY
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Honolulu, HI
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
La Jolla, CA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Myrtle Beach, SC
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Raleigh, NC
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Springfield, OR
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Syracuse, NY
Click here to add this to my saved trials
Prostatic Neoplasms Clinical Trial
Radium-223 Dichloride (BAY88-8223) in Castration-Resistant (Hormone-Refractory) Prostate Cancer Patients With Bone Metastases
Status: Enrolling
Updated: 10/31/2013
Clinical Research Facility
mi
from
Washington DC,
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Provision Proton Therapy Center
mi
from
Knoxville, TN
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Prostate Metabolomic Study
Status: Enrolling, Phase
Updated: 12/31/1969
Georgetown University Hospital
mi
from
Arlington, VA
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/19/2014
Clinical Research Facility
mi
from
Sedona, AZ
Click here to add this to my saved trials
Oncology Clinical Trial
Study of Cabozantinib in Combination With Abiraterone in Chemotherapy-Naïve Subjects With Bone-Metastatic Castration-Resistant Prostate Cancer
Status: Enrolling, Phase II
Updated: 6/19/2014
Clinical Research Facility
mi
from
Wichita, KS
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology, Oncology, Reproductive Clinical Trial
Integrated Cancer Repository for Cancer Research
Status: Enrolling, Phase
Updated: 12/31/1969
St. Vincent Hospital
mi
from
Worcester, MA
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Dana Farber Cancer Institution
mi
from
Boston, MA
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Cancer Treatment Centers of America-Philadelphia
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Hematology, Oncology, Reproductive Clinical Trial
A Study of TAS-120 in Patients With Advanced Solid Tumors
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Mayo Clinic - MN
mi
from
Rochester, MN
Click here to add this to my saved trials
Low Risk Prostate Cancer Clinical Trial
Decision Making in Men With Early Stage Prostate Cancer Patients and Partners/Close Allies
Status: Enrolling, Phase
Updated: 12/31/1969
Memorial Sloan Kettering Westchester
mi
from
Harrison, NY
Click here to add this to my saved trials
Oncology Clinical Trial
AZD8186 First Time In Patient Ascending Dose Study
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Prostate Cancer Clinical Trial
Radiation Hypofractionation Via Extended Versus Accelerated Therapy (HEAT) For Prostate Cancer
Status: Enrolling, Phase III
Updated: 12/31/1969
Northern Sydney Local Health District - Royal North Shore Hospital
mi
from
St. Leonards,
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Anchorage Associates in Radiation Medicine
mi
from
Anchorage, AK
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
PCR Oncology
mi
from
Arroyo Grande, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
AIS Cancer Center at San Joaquin Community Hospital
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Medical Center of Baton Rouge
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Nebraska Medicine-Bellevue
mi
from
Bellevue, NE
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
West Virginia University Charleston Division
mi
from
Charleston, WV
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
University Oncology Associates
mi
from
Clovis, CA
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
Coffeyville Regional Medical Center
mi
from
Coffeyville, KS
Click here to add this to my saved trials
Endocrinology, Hematology, Oncology Clinical Trial
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
Status: Enrolling, Phase II
Updated: 12/31/1969
City of Hope Corona
mi
from
Corona, CA
Click here to add this to my saved trials
1 … 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66